Talus Bioscience, a technology-enabled therapeutics company, today announced new preclinical data from programs targeting transcription factors in chordoma, non-small cell lung cancer, and advanced ...

Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology and ...

Mapping a tumor's cellular neighborhood in three dimensions could identify potential targets for personalized cancer therapy.

Researchers in Nikolaus Rajewsky's lab at Max Delbrück Center combined high-resolution, single-cell spatial technologies to map a tumor's cellular neighborhoods in 3D and identify potential targets ...

Akoya Biosciences (AKYA) announced the availability of a new assay designed to advance antibody-drug conjugate development in breast cancer.

Akoya Biosciences (AKYA) and Enable Medicine announced a collaboration to deliver the largest commercially available single-cell spatial ...

Syncell, a leader in next-generation subcellular protein purification and spatial proteomics analysis, announced the launch of their preferred partner network today. The company's commercial expansion ...

Originally launched at SITC 2024, the PhenoCode Discovery IO60 panel remains the fastest ultrahigh-plex spatial proteomics solution for immuno-oncology research. At AACR 2025, one of Akoya's customers ...

MARLBOROUGH, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, and Enable Medicine, a real-world data company providing AI-ready patient, ...

Ninety posters and presentations at AACR powered by the Standard BioTools proteomic portfolio to advance cancer research from ...

Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ ...

Proteomics profiling of a pre-metastatic colorectal cancer cohort identifies four proteomics-based subtypes and highlights ...